 |
|
|
Three leading analysts and top management from eleven sector firms examine the outlook for Anti-Aging & Longevity Investing in this special 56-page issue from The Wall Street Transcript. |
 |
- Anti-Aging & Longevity Investing - In an-depth (10,800 words) Analyst Interview, Lorne Caplan, Managing Director, Caroline Goodman, Research Analyst, and Scott Baily, Vice President, all at BlueStone Capital Partners, examine the outlook for the sector, demographic-based investing, anti-aging medicine target, and share specific stock recommendations.
- CEO interviews (average 2,500 words). Top management of eleven sector firms examine the outlook for their firm and the sector. Firms include:
Ostex International, Weider Nutrition International, Akorn, Cholestech, HEARx, Medamicus, MotherNature.com, Natrol, PacificHealth Laboratories, PolyMedica, ZEVEX International
This Issue costs $175 - and is non-returnable.
The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.
|
 |

Investors and Industry Execs.
The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.
TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best.
Money manager interviews provide the view from the buy-side.
CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.
Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.
Sincerely,
Andrew Pickup
Publisher
|
|
 |